Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Software & services

Predictiv AI sees surge in demand and interest for its ThermalPass scanners from hospitals across North America

The demand comes amid the installation of ThermalPass systems at one of the largest hospital chains in Florida, as medical facilities ramp up precautions to mitigate the further spread of coronavirus (COVID-19) and its variants

Predictiv AI Inc (CVE:PAI) (OTCMKTS:INOTF) (FRA:71TA) has said it is experiencing a surge in demand and interest for its walk-through temperature scanning system ThermalPass from hospitals across North America as they ramp up pandemic precautions to mitigate the further spread of the coronavirus (COVID-19) and its variants.

The company noted the recent sale and installation of multiple ThermalPass systems at one of the largest and most respected hospital chains in Florida - Memorial Healthcare System (MHS).

MHS chose to install ThermalPass in its south Broward County flagship medical facility in Hollywood and its Pembroke Pines medical center in an effort to add another layer of protection for its patients and staff.

READ: Predictiv AI says its ThermalPass scanners deployed at Iredell-Statesville Schools in North Carolina

"The ThermalPass is on the cutting edge of technology and provides MHS an expeditious solution to temperature screening with incredible accuracy that is far superior to other products we considered," said Dawn de la Vega, director of nursing at Memorial Regional Hospital in a statement.

"The system provides our doctors and staff peace of mind and eliminates human error that is inherent in a manual temperature screening process. The pandemic has challenged healthcare in many ways; as a leader, most of my time is spent removing barriers to care for the clinical staff."

ThermalPass is an AI-assisted touchless temperature screening system that utilizes 24 thermal sensors to take up to 1,200 readings per second, yielding a contactless temperature measurement. It also adheres to individual privacy and recommended social-distancing protocols.

According to ReportLinker.com, the global thermal scanner market size is estimated to grow from US$4.1 billion in 2020 to US$6.7 billion by 2025.

ThermalPass poised for long-term growth

Predictiv AI said ThermalPass is poised for long-term growth with a promising trajectory of sales potential due to the building of a robust best-in-class channel reseller network to leverage its unique and distinctive competencies over other fever-detecting devices.

"We have been working around the clock and are laser-focused in meeting the needs of healthcare professionals across North America and winning in the marketplace," said Michael Lende, CEO of Predictiv AI.

"We have positioned ThermalPass to become the go-to non-contact, automatic, multi-person temperature measurement system for more than 6,000 hospitals, medical centers and clinics around the country. It is the perfect first line of defense for both patients and staff. Our timing couldn't be better since Centers for Disease Control and Prevention (CDC) guidelines recommend that medical facilities screen caregivers, patients, and visitors upon entering the premises."

Using ThermalPass is a stress-free process for patients, visitors, and hospital staff and respects the privacy of individuals since the system is not collecting or storing personal data unlike most camera-based fever detection devices, the company said.

Predictiv AI said it is not making any express or implied claims that its product has the ability to eliminate, cure, or contain the COVID-19 (or SARS-2 coronavirus) at this time.

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK